Remedy Pharmaceuticals
PrivateLast Round
Series D
Dec 1, 2015
Total Funding Raised
$16.7M
Company Overview
Remedy Pharmaceuticals operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series D round in December 2015.
Remedy Pharmaceuticals is a pharmaceutical company that develops therapies for acute central nervous system conditions, including strokes and traumatic brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedy Pharmaceuticals Comparables
Compare Remedy Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aeromics | 91% | |
| Pharmazz, Inc. | 82% | |
| NoNO Inc. | 81% |
For institutional investors. Book with your work email.
Remedy Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 1, 2015 | ||||
| VC Round | Feb 10, 2014 | ||||
| VC Round | Nov 1, 2013 | ||||
| Series B | Jun 1, 2012 | ||||
| Angel | Mar 1, 2012 | ||||
Financing | Sep 8, 2010 |
For institutional investors. Book with your work email.
Remedy Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Vertical Group | Series D |
| Green Circle Capital Partners | Angel, VC Round, Series B |
| Broadview Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 85% MoM.
- Apr 17, 2026
Monthly visitors grew 89% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Remedy Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Remedy Pharmaceuticals's valuation, stock price, and market status.
Is Remedy Pharmaceuticals a public or private company?
Remedy Pharmaceuticals is a private company.
What is the current stock price of Remedy Pharmaceuticals?
Remedy Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Remedy Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remedy Pharmaceuticals worth (valuation)?
Valuation information for Remedy Pharmaceuticals is not publicly available.
Can I buy Remedy Pharmaceuticals stock?
Remedy Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remedy Pharmaceuticals's last funding round?
Remedy Pharmaceuticals's most recent funding round was Series D on December 1, 2015.
Who are the main investors in Remedy Pharmaceuticals?
Key investors in Remedy Pharmaceuticals include Green Circle Capital Partners.
Will Remedy Pharmaceuticals IPO soon?
No public IPO plans have been announced for Remedy Pharmaceuticals.
How can I track Remedy Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Remedy Pharmaceuticals's shares on secondary markets.